HHS Funds U.S.-Based Production of Smallpox and Monkeypox Vaccine

30. August 2022 EHR, EMR, Health, HIPAA 0

HHS will provide approximately $11 million to support the first U.S.-based fill and finish manufacturing of JYNNEOS at Grand River Aseptic Manufacturing.

Powered by WPeMatico